Pharmacokinetics of intravenously administered ciprofloxacin.
about
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state.Dosing Recommendations for Continuous Venovenous Hemodiafiltration with AN69 Filter Membranes and Prismaflex DialyzersPharmacokinetics of ciprofloxacin in cystic fibrosis.Prediction of drug concentration-time data in humans from animals: a comparison of three methods.Antibiotic therapy in aging patients.Activities of pefloxacin and ciprofloxacin against experimental malaria in mice.Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infectionsEffect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models.Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic ratsPharmacokinetics of ciprofloxacin after oral and parenteral administration.The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans.Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microfloraQuantitation of ciprofloxacin in body fluids by high-pressure liquid chromatography.Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.Tissue penetration of ciprofloxacin after single and multiple doses.Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients.Steady-state pharmacokinetics of ciprofloxacin in plasma from patients with nosocomial pneumonia: penetration of the bronchial mucosa.Transcutaneous sampling of ciprofloxacin and 8-methoxypsoralen by electroporation (ETS technique).Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disksDermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique.Inhaled antibiotics for gram-negative respiratory infections.Pharmacokinetics of ciprofloxacin with reference to other fluorinated quinolones.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Treatment of gram-negative infections in patients with renal impairment: new alternatives to aminoglycosides.Pharmacokinetics of ciprofloxacin.Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.Excretion of ciprofloxacin into the large bowel of the rabbit.Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits.Pharmacokinetics of three oral formulations of ciprofloxacin.Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis.Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.Comparative evaluation of ciprofloxacin, enoxacin, and ofloxacin in experimental Pseudomonas aeruginosa pneumonia.Simulation model to predict the fate of ciprofloxacin in the environment after wastewater treatment.Optimal sampling theory and population modelling: application to determination of the influence of the microgravity environment on drug distribution and elimination.Ciprofloxacin enhances T cell function by modulating interleukin activities.Pharmacokinetics of ciprofloxacin in sheep after single intravenous or intramuscular administration.Penetration of ciprofloxacin into bronchial secretions.
P2860
Q28360184-51B87590-62F9-4AA3-A273-4474BB99DF37Q33188075-58A31191-FE16-44DB-8C8F-076C74D2BE0AQ33681401-F0FB3522-F03E-431C-B3DD-304D99274137Q33741046-2A4A1650-CF1A-497B-986B-AAAC581BB652Q34168842-7750B6E2-F0E8-4D5A-8126-C4C674A170C3Q35119901-F276F2EE-25C6-4053-9410-873EB0911947Q35284671-2C8F0EF9-B93A-4126-8EDC-B0E1137A315DQ35536186-DC7FE106-A4A8-4E94-8DAE-EF5D3402ED08Q35542198-4B12CC4C-8F6A-4F54-B916-70C1D25377AAQ35543462-CA6207F6-2B5C-42F8-AE3B-EE3C60BFA4A2Q35543546-41FB4976-FCCD-4FD1-A27B-818521BEE3CFQ35570646-2BFD5B87-CF4F-433E-BEC9-691B585A1302Q35572870-9497D081-96F2-4C90-8CDC-01B58AA2D468Q35573482-004A8FF7-0F4B-47EB-BE90-7CA2C3FFCB41Q35642422-9A4DD2A4-4992-4608-8F89-D877189F351FQ35646379-2A63C711-116A-4DA6-BD62-97C2A7E0F3F5Q35649002-F4834FDD-881E-4EAB-BCCC-6DD688E4CD80Q35651376-7C38EA90-5DB9-4B9C-85DF-335C996C21C0Q36757441-A75A84E7-70E6-4F58-BA8E-DAEED0A9E060Q37183990-41FB76FF-0529-48DA-B713-9F0203ECC00DQ37281766-22EE54A0-F8A1-4A6D-B2A8-E40346AA820BQ37335289-CC9B6CFE-7097-4FF6-B2F4-B1259A436219Q37937558-468ABAAE-E4BB-4E22-8A44-6B26FEBD84CDQ38271416-80ACB22A-AB08-4E5F-8D8F-0FBDEBD99D16Q39214819-119BB039-AFBB-44E6-8CBE-078FA1BEFCE2Q39558431-D98C6FB1-E4A5-4A01-BEE2-76C3B1384E5AQ39642479-D7DF9827-9CEB-473C-A4C1-E69DB4CD3217Q39730719-461FD38F-9E69-405D-BFEA-DC01AF9FB070Q39781114-C856674B-4FC1-41C3-A228-26E488A2BE7FQ39827957-083902A1-1C91-4815-A6B1-BBF488F2D5EBQ39828385-2B7C3F45-1DFB-42C6-81DC-65F23BA8EB81Q39834098-33A05607-6C6D-4D3D-AEFF-BE5FDD59A062Q39834702-8D46C0FF-1D28-4234-AFEA-F6A55B3EE82FQ39850707-6ABAC0C2-1A15-4239-9BBA-A3060625DB4EQ39850865-79A453F2-1263-442D-BE1C-9EF3136DFE84Q40094903-E31CBC2C-D562-46AE-9254-B12A14F632BCQ40744378-0B81EA15-D960-430E-955A-9C4963F76884Q41654061-ED81E990-01B7-427D-A0B3-53C6A715339FQ42637703-C54E2F80-0F60-4FF3-AFDC-6A94CE2F3EADQ43635583-A94F62A2-EF73-4805-8FF9-61DBC658EAD2
P2860
Pharmacokinetics of intravenously administered ciprofloxacin.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Pharmacokinetics of intravenously administered ciprofloxacin.
@en
type
label
Pharmacokinetics of intravenously administered ciprofloxacin.
@en
prefLabel
Pharmacokinetics of intravenously administered ciprofloxacin.
@en
P2093
P2860
P356
P1476
Pharmacokinetics of intravenously administered ciprofloxacin.
@en
P2093
P2860
P304
P356
10.1128/AAC.26.2.208
P407
P577
1984-08-01T00:00:00Z